siRNA treatment decreases triglycerides in patients along with rare condition
.RESEARCH EMPHASIZE.19 September 2024.
Plozasiran decreased triglyceride amounts through 80% and also reduced the risk of pancreatitis in clients with constant chylomicronemia, along with or even without a genetic diagnosis.